CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mylan Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mylan Laboratories Ltd
Plot No 564/A/22, Road No 92
Jubilee Hills
Phone: +91 4030866666p:+91 4030866666 Hyderabad, 500034  India Fax: +91 4030866699f:+91 4030866699
This is a Subsidiary, click here for the Parent Company
Business Summary
Mylan Laboratories Limited is an India-based generics and specialty pharmaceutical company, which is engaged in manufacturing and marketing generic pharmaceuticals to retail, wholesale, government and institutional customers. The Company's product categories include human immunodeficiency virus (HIV) Care Products, Women's Care Products, Infertility Care Products, Onco Care Products and Critical Care Products. It offers a portfolio of antiretroviral (ARV) products for the treatment of HIV or acquired immunodeficiency syndrome (AIDS). In addition, it focuses on therapies, such as hormone replacement therapy (HRT). Its other product offerings include purified forms of follicle stimulating hormone, human menopausal gonadotropins, human chorionic gonadotropins, anti-fungal, antibiotic and anticoagulant therapies. It offers a portfolio of approximately 1,300 generic pharmaceuticals and several brand medications. It markets its products in approximately 140 countries and territories.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20103/31/2010Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Acting Chief Executive Officer, Chief Operating Officer, Executive Director B. HariBabu 47 1/1/2012 1/1/2001
Chief Compliance Officer, General Counsel RajeevMukundan 39 12/1/2009 12/1/2009
Head - Finance, Executive Director SusantoBanerjee 45 1/1/2012 12/1/2009
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Docpharma NV
Jai Pharma
Matrix Laboratories BV
Matrix Laboratories NV
Value Pharma International NV

General Information
Number of Employees: 3,005 (As of 3/31/2009)
Outstanding Shares: 156,338,811 (As of 3/31/2010)
Shareholders: 33,944
Stock Exchange: BOM
Fax Number: +91 4030866699


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023